AMWL
American Well Corporation
Medical - Healthcare Information Services
Market Cap$119M
5Y Perf.-98.8%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
AMWL vs DBVT
Revenue, margins, valuation, and 5-year total return — side by side.
DBVT
DBV Technologies S.A.
Biotechnology
Market Cap$1721.78T
5Y Perf.+16.2%
AMWL vs DBVT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | AMWL | DBVT |
|---|---|---|
| Industry | Medical - Healthcare Information Services | Biotechnology |
| Market Cap | $119M | $1721.78T |
| Revenue (TTM) | $182M | $0.00 |
| Net Income (TTM) | $-88M | $-168M |
| Gross Margin | 38.7% | — |
| Operating Margin | -50.6% | — |
| Total Debt | $5M | $22M |
| Cash & Equiv. | $182M | $194M |
AMWL vs DBVT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
AMWL
DBVT
| Stock | Sep 20 | May 26 | Return |
|---|---|---|---|
| American Well Corpo… (AMWL) | 100 | 1.2 | -98.8% |
| DBV Technologies S.… (DBVT) | 100 | 116.2 | +16.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AMWL vs DBVT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: DBVT leads in 3 of 6 categories, making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. American Well Corporation is the stronger pick specifically for growth and revenue expansion and operational efficiency and capital deployment. As sector peers, any of these can serve as alternatives in the same allocation.
AMWL
American Well Corporation
The Growth Play
AMWL is the clearest fit if your priority is growth exposure.
- Rev growth -2.0%, EPS growth 57.1%, 3Y rev CAGR -3.5%
- -2.0% revenue growth vs DBVT's -100.0%
- -25.1% ROA vs DBVT's -89.0%
Best for: growth exposure
DBVT
DBV Technologies S.A.
The Income Pick
DBVT carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 0 yrs, beta 1.26
- -86.8% 10Y total return vs AMWL's -98.5%
- Lower volatility, beta 1.26, Low D/E 12.8%, current ratio 3.67x
Best for: income & stability and long-term compounding
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | AMWL | -2.0% revenue growth vs DBVT's -100.0% |
| Quality / Margins | DBVT | 0.3% margin vs AMWL's -48.2% |
| Stability / Safety | DBVT | Beta 1.26 vs AMWL's 1.47 |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | DBVT | +114.1% vs AMWL's +5.3% |
| Efficiency (ROA) | AMWL | -25.1% ROA vs DBVT's -89.0% |
AMWL vs DBVT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2025
Segment breakdown not available.
AMWL vs DBVT — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLAMWLLAGGINGDBVT
DBVTDBV Technologies S.A.
2leads
AMWLAmerican Well Corpora…
2leads
6 Total Categories
CATEGORYLEADERvs DBVTMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
DBVT1/1
Valuation MetricsMultiples, price ratios, and targets
AMWL2/2
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
AMWL7/8
Total Returns1Y, 3Y, 5Y total returns with dividends
DBVT5/6
Risk & VolatilityBeta, volatility, and downside exposure
Tied
—
Analyst OutlookRatings, price targets, and dividends
—
—
Income & Cash Flow (Last 12 Months)
DBVT leads this category, winning 1 of 1 comparable metric.
Income & Cash Flow (Last 12 Months)
AMWL and DBVT operate at a comparable scale, with $182M and $0 in trailing revenue.
| Metric | AMWLAmerican Well Cor… | DBVTDBV Technologies … |
|---|---|---|
| RevenueTrailing 12 months | $182M | $0 |
| EBITDAEarnings before interest/tax | -$59M | -$112M |
| Net IncomeAfter-tax profit | -$88M | -$168M |
| Free Cash FlowCash after capex | -$42M | -$151M |
| Gross MarginGross profit ÷ Revenue | +38.7% | — |
| Operating MarginEBIT ÷ Revenue | -50.6% | — |
| Net MarginNet income ÷ Revenue | -48.2% | — |
| FCF MarginFCF ÷ Revenue | -22.9% | — |
| Rev. Growth (YoY)Latest quarter vs prior year | -100.0% | — |
| EPS Growth (YoY)Latest quarter vs prior year | +44.5% | +91.5% |
DBVT leads this category, winning 1 of 1 comparable metric.
Valuation Metrics
AMWL leads this category, winning 2 of 2 comparable metrics.
Valuation Metrics
| Metric | AMWLAmerican Well Cor… | DBVTDBV Technologies … |
|---|---|---|
| Market CapShares × price | $119M | $1721.78T |
| Enterprise ValueMkt cap + debt − cash | -$59M | $1721.78T |
| Trailing P/EPrice ÷ TTM EPS | -1.20x | -0.76x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | — |
| Price / SalesMarket cap ÷ Revenue | 0.48x | — |
| Price / BookPrice ÷ Book value/share | 0.46x | 0.66x |
| Price / FCFMarket cap ÷ FCF | — | — |
AMWL leads this category, winning 2 of 2 comparable metrics.
Profitability & Efficiency
AMWL leads this category, winning 7 of 8 comparable metrics.
Profitability & Efficiency
AMWL delivers a -33.5% return on equity — every $100 of shareholder capital generates $-33 in annual profit, vs $-130 for DBVT. AMWL carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to DBVT's 0.13x. On the Piotroski fundamental quality scale (0–9), AMWL scores 6/9 vs DBVT's 4/9, reflecting solid financial health.
| Metric | AMWLAmerican Well Cor… | DBVTDBV Technologies … |
|---|---|---|
| ROE (TTM)Return on equity | -33.5% | -130.2% |
| ROA (TTM)Return on assets | -25.1% | -89.0% |
| ROICReturn on invested capital | -95.1% | — |
| ROCEReturn on capital employed | -36.6% | -145.7% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 4 |
| Debt / EquityFinancial leverage | 0.02x | 0.13x |
| Net DebtTotal debt minus cash | -$178M | -$172M |
| Cash & Equiv.Liquid assets | $182M | $194M |
| Total DebtShort + long-term debt | $5M | $22M |
| Interest CoverageEBIT ÷ Interest expense | -239.18x | -189.82x |
AMWL leads this category, winning 7 of 8 comparable metrics.
Total Returns (Dividends Reinvested)
DBVT leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in DBVT five years ago would be worth $3,344 today (with dividends reinvested), compared to $262 for AMWL. Over the past 12 months, DBVT leads with a +114.1% total return vs AMWL's +5.3%. The 3-year compound annual growth rate (CAGR) favors DBVT at 6.4% vs AMWL's -43.8% — a key indicator of consistent wealth creation.
| Metric | AMWLAmerican Well Cor… | DBVTDBV Technologies … |
|---|---|---|
| YTD ReturnYear-to-date | +47.4% | +5.5% |
| 1-Year ReturnPast 12 months | +5.3% | +114.1% |
| 3-Year ReturnCumulative with dividends | -82.2% | +20.4% |
| 5-Year ReturnCumulative with dividends | -97.4% | -66.6% |
| 10-Year ReturnCumulative with dividends | -98.5% | -86.8% |
| CAGR (3Y)Annualised 3-year return | -43.8% | +6.4% |
DBVT leads this category, winning 5 of 6 comparable metrics.
Risk & Volatility
Evenly matched — AMWL and DBVT each lead in 1 of 2 comparable metrics.
Risk & Volatility
DBVT is the less volatile stock with a 1.26 beta — it tends to amplify market swings less than AMWL's 1.47 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | AMWLAmerican Well Cor… | DBVTDBV Technologies … |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.47x | 1.26x |
| 52-Week HighHighest price in past year | $9.15 | $26.18 |
| 52-Week LowLowest price in past year | $3.71 | $7.53 |
| % of 52W HighCurrent price vs 52-week peak | +78.1% | +76.8% |
| RSI (14)Momentum oscillator 0–100 | 58.1 | 43.8 |
| Avg Volume (50D)Average daily shares traded | 58K | 253K |
Evenly matched — AMWL and DBVT each lead in 1 of 2 comparable metrics.
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
| Metric | AMWLAmerican Well Cor… | DBVTDBV Technologies … |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $46.33 |
| # AnalystsCovering analysts | — | 15 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | 0 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.0% | 0.0% |
Insufficient data to determine a leader in this category.
Key Takeaway
DBVT leads in 2 of 6 categories (Income & Cash Flow, Total Returns). AMWL leads in 2 (Valuation Metrics, Profitability & Efficiency). 1 tied.
Best OverallAmerican Well Corporation (AMWL)Leads 2 of 6 categories
Loading custom metrics...
AMWL vs DBVT: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is AMWL or DBVT a better buy right now?
Analysts rate DBV Technologies S.
A. (DBVT) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — AMWL or DBVT?
Over the past 5 years, DBV Technologies S.
A. (DBVT) delivered a total return of -66. 6%, compared to -97. 4% for American Well Corporation (AMWL). Over 10 years, the gap is even starker: DBVT returned -86. 8% versus AMWL's -98. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — AMWL or DBVT?
By beta (market sensitivity over 5 years), DBV Technologies S.
A. (DBVT) is the lower-risk stock at 1. 26β versus American Well Corporation's 1. 47β — meaning AMWL is approximately 17% more volatile than DBVT relative to the S&P 500. On balance sheet safety, American Well Corporation (AMWL) carries a lower debt/equity ratio of 2% versus 13% for DBV Technologies S. A. — giving it more financial flexibility in a downturn.
04Which is growing faster — AMWL or DBVT?
On earnings-per-share growth, the picture is similar: American Well Corporation grew EPS 57.
1% year-over-year, compared to -347. 5% for DBV Technologies S. A.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — AMWL or DBVT?
DBV Technologies S.
A. (DBVT) is the more profitable company, earning 0. 0% net margin versus -38. 4% for American Well Corporation — meaning it keeps 0. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DBVT leads at 0. 0% versus -42. 2% for AMWL. At the gross margin level — before operating expenses — AMWL leads at 53. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — AMWL or DBVT?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is AMWL or DBVT better for a retirement portfolio?
For long-horizon retirement investors, DBV Technologies S.
A. (DBVT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 26)). Both have compounded well over 10 years (DBVT: -86. 8%, AMWL: -98. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between AMWL and DBVT?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.